- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Shantanu Agrawal Highlights Progress Being Made to Address Health Inequities
Addressing health disparities and social determinants of health can be daunting, but there has been a lot of progress, said Shantanu Agrawal, MD, MPhil, CEO and president of National Quality Forum.
Addressing health disparities and social determinants of health can be daunting, but there has been a lot of progress, said Shantanu Agrawal, MD, MPhil, CEO and president of National Quality Forum.
Transcript
What progress have you seen in better addressing disparities and social determinants of health?
I think the great news is that there is a lot of progress. This can be a topic that can seem really daunting to clinicians to communities and clearly it’s a challenge that we have to rise to but the fantastic news is that there are clearly communities and delivery systems that are working hard in the area and actually making progress.
If you look across the country you can see delivery systems, working on transportation and security, working on primary care, on food and security, trying to remedy those things directly for citizens and patients to work directly by partnering with their local community and government. There’s actually quite a bit of that activity.
One of the lessons learned from our work is despite all the activity, we are really bad at disseminating that information and knowing what each other is doing. A basic activity that might all engage in is sharing that information sharing what practices are, what scientifically rigorous practices are on dealing with health inequities. So that we are all kind of driving towards the same goal together. But there’s a lot of great work to build on which remains the happy and optimistic news.
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Posters Characterize DMD Caregiver Experiences, Impact of Gene Therapy on Caregiving Demands
May 10th 2024Posters presented at the ISPOR—The Professional Society for Health Economics and Outcomes Research meeting explored Duchenne muscular dystrophy (DMD) caregiver experiences and gene therapy’s impact on work opportunities for caregivers.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Budesonide-Based Triple Therapy Shows Best Benefit Over Dual Therapy for COPD
May 8th 2024The triple therapy of budesonide, glycopyrrolate, and formoterol fumarate showed the greatest incremental net benefit among a series of triple therapy medications that were evaluated against dual therapy for chronic obstructive pulmonary disease (COPD), according to an analysis presented at ISPOR.
Read More
